Low-Dose Daily Subcutaneous Interleukin-2 in Combination with Highly Active Antiretroviral Therapy in HIV + Patients: A Randomized Controlled Trial

Antiretroviral Therapy ◽

Low Dose ◽

Controlled Trial ◽

Interleukin 2 ◽

Hiv Patients ◽

Randomized Controlled ◽

Randomized Controlled Trial: 4 Month versus 6 Month Monitoring of HIV-infected Patients on Highly Active Antiretroviral Therapy

Journal of Community Health ◽

10.1007/s10900-016-0188-4 ◽

2016 ◽

Vol 41 (5) ◽

pp. 1044-1048 ◽

Cited By ~ 2

Author(s):

Sharon Weissman ◽

Sarah Singh ◽

Shana Dykema ◽

R. David Parker

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Randomized Controlled ◽

A Prospective Randomized Controlled Trial of Structured Treatment Interruption in HIV-Infected Patients Failing Highly Active Antiretroviral Therapy (Canadian HIV Trials Network Study 164)

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0b013e318061b611 ◽

2007 ◽

Vol 45 (4) ◽

pp. 418-425 ◽

Cited By ~ 8

Author(s):

Sharon L Walmsley ◽

Anona Thorne ◽

Mona R Loutfy ◽

Natasha LaPierre ◽

John MacLeod ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Prospective Randomized Controlled Trial

Controlled Trial ◽

Treatment Interruption ◽

Randomized Controlled ◽

Highly Active ◽

A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0b013e318251aedd ◽

2012 ◽

Vol 60 (2) ◽

pp. 150-157 ◽

Cited By ~ 85

Author(s):

Anisa Mosam ◽

Fahmida Shaik ◽

Thomas S. Uldrick ◽

Tonya Esterhuizen ◽

Gerald H. Friedland ◽

...

Keyword(s):

South Africa ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Kaposi Sarcoma ◽

Randomized Controlled ◽

Annual Zoledronate Increases Bone Density in Highly Active Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Men: A Randomized Controlled Trial

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2006-2216 ◽

2007 ◽

Vol 92 (4) ◽

pp. 1283-1288 ◽

Cited By ~ 93

Author(s):

Mark J. Bolland ◽

Andrew B. Grey ◽

Anne M. Horne ◽

Simon E. Briggs ◽

Mark G. Thomas ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Antiretroviral Therapy ◽

Bone Density ◽

Controlled Trial ◽

Randomized Controlled ◽

Highly Active ◽

Immunodeficiency Virus

Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients

AIDS ◽

10.1097/00002030-199817000-00003 ◽

1998 ◽

Vol 12 (17) ◽

pp. F225-F234 ◽

Cited By ~ 76

Author(s):

Ulrich R. Hengge ◽

Manfred Goos ◽

Stefan Esser ◽

Vanessa Exner ◽

Heidi Dötterer ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Hiv Patients ◽

Randomized Controlled ◽

DYNAMICS OF CLINICAL LABORATORY PARAMETER IN HIV-INFECTED CHILDREN UNDERGOING DIFFERENT PATTERNS OF INITIAL HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: RANDOMIZED CONTROLLED TRIAL

Педиатрическая фармакология ◽

10.15690/pf.v13i1.1510 ◽

2016 ◽

Vol 13 (1) ◽

pp. 22-26

Author(s):

V. B. Denisenko ◽

E. N. Simovanyan

Keyword(s):

Antiretroviral Therapy ◽

Clinical Laboratory ◽

Controlled Trial ◽

Laboratory Parameter ◽

Randomized Controlled ◽

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells

Clinical Immunology ◽

10.1016/s1521-6616(02)00038-4 ◽

2003 ◽

Vol 106 (3) ◽

pp. 188-196 ◽

Cited By ~ 18

Author(s):

Alberdina W de Boer ◽

Norman Markowitz ◽

H.Clifford Lane ◽

Louis D Saravolatz ◽

Susan L Koletar ◽

...

Keyword(s):

T Cells ◽

Antiretroviral Therapy ◽

Cd4 T Cells ◽

Controlled Trial ◽

Interleukin 2 ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Hiv Seropositive

Combination of Niacin and Fenofibrate with Lifestyle Changes Improves Dyslipidemia and Hypoadiponectinemia in HIV Patients on Antiretroviral Therapy: Results of “Heart Positive,” a Randomized, Controlled Trial

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2010-3067 ◽

2011 ◽

Vol 96 (7) ◽

pp. 2236-2247 ◽

Cited By ~ 45

Author(s):

Ashok Balasubramanyam ◽

Ivonne Coraza ◽

E. O'Brian Smith ◽

Lynne W. Scott ◽

Payal Patel ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Lifestyle Changes ◽

Hiv Patients ◽

Randomized Controlled

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals

AIDS ◽

10.1097/qad.0b013e3282f511f1 ◽

2008 ◽

Vol 22 (6) ◽

pp. 737-740 ◽

Cited By ~ 6

Author(s):

Brian Angus ◽

Fiona Lampe ◽

Guiseppe Tambussi ◽

Claudine Duvivier ◽

Christine Katlama ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Controlled Trial ◽

Interleukin 2 ◽

Randomized Controlled ◽

Hiv 1

Change in body mass index (BMI) after highly active antiretroviral therapy among hiv patients in kano, Northwestern Nigeria

Endocrine Abstracts ◽

10.1530/endoabs.48.p10 ◽

2017 ◽

Author(s):

Fakhraddeen Muhammad ◽

Mansur Ramalan ◽

Adenike Enikuomehin

Keyword(s):

Body Mass Index ◽

Antiretroviral Therapy ◽

Body Mass ◽

Hiv Patients ◽